Skip to main content
Premium Trial:

Request an Annual Quote

Andrew Brooks

Circuit Clinical, an integrated research organization that facilitates clinical trials and biospecimen collection, has added Andrew Brooks to its board of directors. Brooks is currently chief operating officer of RUCDR Infinite Biologics (RUCDR) at Rutgers University, the world's largest academic biorepository managing biological resources for clients such as the National Institutes of Health, as well as leading academic researchers and major pharmaceutical and biotechnology companies. He is a professor of genetics at Rutgers University and a member of the Human Genetics Institute of New Jersey.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.